Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia.
Gladwin
M T
MT
Department of Critical Care Medicine, NIDDK National Institutes of Health, Bethesda, Maryland, USA.
Rodgers
G P
GP
D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000503:physiopathology; D000986:Antisickling Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D009569:Nitric Oxide / Q000627:therapeutic use; D012128:Respiratory Distress Syndrome / Q000209:etiology* / Q000628:therapy*; D013577:Syndrome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000986:Antisickling Agents; D014665:Vasodilator Agents; D009569:Nitric Oxide; D006918:Hydroxyurea